K Number
K961219
Device Name
PERCUTANEOUS INTRODUCER SYSTEM
Date Cleared
1996-06-21

(85 days)

Product Code
Regulation Number
878.4350
AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdparty
Intended Use
The proposed kit is indicated for suprapubic bladder drainage and percutancous access for the placement of theminsensor probes in patients undergoing ultrasound-guided urological cryosurgery procedures in accordance with the indications of legally marketed cryosurgery systems.
Device Description
The kit is comprised of guidewire(s), access needles(s), dilator(s), divinage catheter with connecting tube, scalpel and syringe.
More Information

Not Found

Not Found

No
The summary describes a kit of standard medical devices for drainage and access, with no mention of AI or ML capabilities.

No
The device is used for drainage and access during cryosurgery procedures, which are therapeutic interventions, but the device itself is an accessory used for access and drainage, not for directly treating a disease or condition.

No
This device is for suprapubic bladder drainage and percutaneous access for placement of probes, which are interventional procedures rather than diagnostic ones.

No

The device description explicitly lists physical components such as guidewires, needles, catheters, scalpel, and syringe, indicating it is a hardware-based medical device kit.

No, this device is not an IVD (In Vitro Diagnostic).

Here's why:

  • IVD Definition: In vitro diagnostics are tests performed on samples such as blood, urine, or tissue that have been taken from the human body to detect diseases, conditions, or infections.
  • Device Description and Intended Use: The description and intended use of this device clearly indicate it is a kit for surgical access and drainage within the body (suprapubic bladder drainage and percutaneous access for probe placement). It is used during a medical procedure, not for testing samples outside the body.

Therefore, based on the provided information, this device falls under the category of a surgical or procedural device, not an IVD.

N/A

Intended Use / Indications for Use

The proposed kit is indicated for suprapubic bladder drainage and percutancous access for the placement of theminsensor probes in patients undergoing ultrasound-guided urological cryosurgery procedures in accordance with the indications of legally marketed cryosurgery systems.

Product codes

Not Found

Device Description

The kit is comprised of guidewire(s), access needles(s), dilator(s), divinage catheter with connecting tube, scalpel and syringe.

Mentions image processing

Not Found

Mentions AI, DNN, or ML

Not Found

Input Imaging Modality

ultrasound-guided

Anatomical Site

suprapubic bladder

Indicated Patient Age Range

Not Found

Intended User / Care Setting

Not Found

Description of the training set, sample size, data source, and annotation protocol

Not Found

Description of the test set, sample size, data source, and annotation protocol

Not Found

Summary of Performance Studies

Not Found

Key Metrics

Not Found

Predicate Device(s)

Not Found

Reference Device(s)

Not Found

Predetermined Change Control Plan (PCCP) - All Relevant Information

Not Found

§ 878.4350 Cryosurgical unit and accessories.

(a)
Identification —(1)Cryosurgical unit with a liquid nitrogen cooled cryoprobe and accessories. A cryosurgical unit with a liquid nitrogen cooled cryoprobe and accessories is a device intended to destroy tissue during surgical procedures by applying extreme cold.(2)
Cryosurgical unit with a nitrous oxide cooled cryoprobe and accessories. A cryosurgical unit with a nitrous oxide cooled cryoprobe and accessories is a device intended to destroy tissue during surgical procedures, including urological applications, by applying extreme cold.(3)
Cryosurgical unit with a carbon dioxide cooled cryoprobe or a carbon dioxide dry ice applicator and accessories. A cryosurgical unit with a carbon dioxide cooled cryoprobe or a carbon dioxide dry ice applicator and accessories is a device intended to destroy tissue during surgical procedures by applying extreme cold. The device is intended to treat disease conditions such as tumors, skin cancers, acne scars, or hemangiomas (benign tumors consisting of newly formed blood vessels) and various benign or malignant gynecological conditions affecting vulvar, vaginal, or cervical tissue. The device is not intended for urological applications.(b)
Classification. Class II.

0

Boston Scientific Corporation January 10, 1996

JUN 21 1998

510(k) Premarket Notification Percuataneous Introducer System

FOI RELEASABLE

K961219

510(K) Summary

Pursuant to §513(i)(3)(A) of the Food, Drug, and cosmetic Act, Boston Scientific Corporation is required to submit with this Prematket Notification". . . adequate summary of any information respecting safety and effectivencss or state that such information will be made available upon request of any person." Boston Scientific Corporation chooses to submit a summary of information respecting safety and effectiveness.

Date:January 10, 1996
Owner Operator Submitting this Premarket Notification:Boston Scientific Corporation
480 Pleasant Street
Watertown, MA 02172
(508) 650-8000
Contact Person:Lorraine M. Hanley
Project Manager, Regulatory Affairs
Device Common Name:Percutaneous Introducer System
Device Trade Name:To be Determined
Classification Name:Boston Scientific Corporation believes that the Percutaneous
Introducer System is best described by the following device
classification names:
Catheter Introducer:
Class 11, CFR 870.1340
Introducer/Drainage Catheter and Accessories
Class I, 21 CFR 878.4200

Device Description & Intended Use:

The kit is comprised of guidewire(s), access needles(s), dilator(s), divinage catheter with connecting tube, scalpel and syringe. The proposed kit is indicated for suprapubic bladder drainage and percutancous access for the placement of theminsensor probes in patients undergoing ultrasound-guided urological cryosurgery procedures in accordance with the indications of legally marketed cryosurgery systems.

Substantial Equivalence:

All components of the proposed kit are either legally marketed preamendment devices, exempt form 510(k) Premarket Notification or have been found to be substantially equivalent through the 510(k) process for the uses for which the kit is intended.

Conclusions:

Based on the information presented in this current premarket notification, Boston Scientific Corporation believes that the proposed Percutanous Introducer System is safe and effective, that it will meet the minimum requirencents that are considered acceptable for its intended use, and that a determination of "substantial equivalence" is supported.